Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.50    1.50 (2.14%)
Bid:
71.00
Ask:
72.00
Spread: 1.00 (1.408%)
Market Cap: £325.40m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Director/PDMR Shareholding

8 Jan 2009 14:29

RNS Number : 3467L
Avacta Group PLC
08 January 2009
 

Avacta Group plc

("Avacta" or "the Company")

Director/PDMR Shareholding

Pursuant to the announcements made on 22 July 2008 and 20 November 2008 in relation to the holding of ordinary shares of 0.1p each ("Ordinary Shares") by Alastair Smith, Chief Executive Officer, the Board of the Company would now wish to clarify his resultant beneficial holding.

Following the sales of 601,389 Ordinary Shares and 3,061,464 Ordinary Shares to Alastair's Self Invested Pension Plan ("SIPP"), his correct resultant beneficial holding is 49,577,022 Ordinary Shares, representing approximately 6.02 per cent. of the current issued share capital of the Company. A total of 40,446 Ordinary Shares were sold at the time of the transactions in order to satisfy settlement and commission charges.

For further information, please contact:

Avacta Group plc 

Alastair Smith, Chief Executive Officer

Tim Sykes, Chief Financial Officer

www.avacta.com

Tel: 0870 835 4367

Daniel Stewart & Company plc 

Lindsay Mair/Tessa Smith

www.danielstewart.co.uk

Tel: 020 7776 6550

Novum Securities Limited

Henry Turcan/Michael Brennan

Tel: 020 7562 4700

Haggie Financial LLP 

Nicholas Nelson/Kathy Boate

Nicholas.nelson@haggie.co.uk

Tel: 020 7417 8989

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSCKFKBQBKDFDK
Date   Source Headline
7th Aug 20097:00 amPRNPre-Close Trading Statement
28th Jul 20095:07 pmRNSHolding(s) in Company
13th Jul 20094:40 pmRNSDirector/PDMR Shareholding
10th Jul 20094:17 pmRNSIssue of Equity
9th Jul 20094:29 pmRNSFurther re Acquisition of Theragenetics Limited
23rd Apr 20097:00 amRNSHalf Yearly Report
23rd Apr 20097:00 amPRNOPTIM Product Launch
31st Mar 200912:20 pmPRNAnalyst Presentation
30th Mar 200912:59 pmPRNDirector/PDMR Shareholding
3rd Mar 20091:17 pmRNSCompletion of Acquisition of Curidium Medica plc
2nd Mar 200912:00 pmRNSResult of Court Hearing
12th Feb 20091:23 pmRNSRule 8.1- (Curidium Medica Plc)
11th Feb 20092:09 pmRNSResults of meetings
9th Feb 200912:39 pmRNSResult of EGM
9th Feb 20097:00 amPRNAcquisition
26th Jan 20097:00 amPRNResult of AGM
16th Jan 20097:00 amRNSOffer Update
15th Jan 20099:24 amPRNAcquisition of Theragenetics Limited
9th Jan 200910:12 amRNSAvacta Group plc Acquisition
9th Jan 20097:00 amPRNAcquisition(s)
8th Jan 20092:29 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSIssue of Equity
12th Dec 200812:06 pmRNSFinal Results
20th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 200812:42 pmRNSIssue of Equity
4th Nov 20087:00 amPRNFinal Results
13th Oct 20087:00 amPRNChange of Adviser
11th Sep 20087:00 amPRNProduct Launch
21st Aug 20087:00 amPRNTrading Statement
14th Aug 200811:03 amPRNProduct Development Partnership
28th Jul 20087:00 amPRNProduct Launch
23rd Jul 20082:54 pmPRNDirector/PDMR Shareholding
14th Apr 20087:00 amPRNHalf-yearly Report
4th Apr 20085:20 pmRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSTotal Voting Rights
10th Mar 20083:12 pmRNSIssue of Equity
31st Jan 200811:36 amRNSTotal Voting Rights
7th Jan 200810:50 amPRNRe Agreement
31st Dec 20077:00 amPRNTotal Voting Rights
14th Dec 20073:30 pmPRNAcquisition(s)
14th Dec 20073:05 pmPRNAGM Statement
21st Nov 20077:01 amRNSNotice of AGM
14th Nov 20079:08 amPRNAcquisition
9th Nov 20074:59 pmPRNDirectorate Appointment
25th Sep 20077:00 amPRNFinal Results
3rd Sep 20077:00 amPRNRe Agreement
14th Aug 20073:59 pmRNSAIM Rule 26 Information
13th Aug 20077:00 amPRNRe Agreement
31st Jul 20073:37 pmRNSTotal Voting Rights
26th Jul 20079:53 amPRNIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.